Global Health Limited (Medanta) has released its investor presentation for the second quarter and first half of FY2027. The document details significant revenue growth of 34% YoY in Q2 FY27, driven by increased patient volumes. It also outlines capacity expansion projects, business updates, and the company’s strategic journey and healthcare model. Key financial metrics including Operating EBITDA and PAT growth are also highlighted.
Global Health Limited Investor Presentation Highlights
Global Health Limited, operating under the brand Medanta, has released its investor presentation detailing the company’s performance for Q2 and H1 FY2027. The presentation, dated November 14, 2026, showcases robust financial and operational achievements.
Q2 and H1 FY2027 Performance Summary
The company reported a strong revenue growth of 34% year-on-year (YoY) in Q2 FY27, primarily attributed to an increase in patient volumes. Revenue from operations reached INR 14,690 million for Q2 FY27, a 33.6% increase YoY. Operating EBITDA saw a significant growth of 60.2% YoY to INR 3,701 million, with margins improving to 25.2%. Profit After Tax (PAT) grew by 38.3% YoY to INR 2,191 million.
For H1 FY27, revenue from operations stood at INR 27,731 million, a 30.2% increase YoY. Operating EBITDA for the first half grew by 43.4% YoY to INR 6,568 million, with margins at 23.7%. PAT for H1 FY27 was INR 3,764 million, an 18.6% increase YoY.
Business Updates and Expansion
The presentation also covers key business updates, including capacity expansion initiatives. Noida hospital is now operational with 482 beds, and Lucknow has added 25 beds, bringing its total to 803 beds. Several new projects are underway, including planned additions in South Delhi, Pitampura, Mumbai, Guwahati, Varanasi, Indore, and Ghaziabad, aiming to add approximately 3,450 beds. The total estimated capex plan for the next 4-5 years is around INR 62,390 million.
Medanta’s Model and Vision
The document further elaborates on Medanta’s journey, its purpose, and its unique model of healthcare, emphasizing a patient-centric approach, exceptional clinical talent, world-class infrastructure, and advanced technology. The company’s mission is to deliver world-class, patient-centric, integrated, and affordable healthcare.
Financial and Operational Parameters
Annexures provide detailed financial performance, including a Profit and Loss statement, and operational parameters such as total beds, census beds, occupied bed days, occupancy rate, ARPP, ALOS, and patient volumes. The company also detailed its abbreviations and definitions for clarity.
Source: BSE
